La radioterapia preoperatoria nel cancro del retto: Frazionamento convenzionale

Translated title of the contribution: Preoperative radiation therapy for rectal cancer: Conventional fractionation

A. De Paoli, E. Maranzano, S. Neri

Research output: Contribution to journalArticle

Abstract

Experiences on preoperative radiation therapy with conventional fractionation for rectal cancer are reviewed. Results in terms of local control, survival and sphincter preservation are focused in resectable disease: the impact on resectability, local control and survival are analysed in unresectable disease. Randomized trials reported in the 80s, demonstrated a significant impact on local control with a pre-op dose of 34.5-40 Gy vs surgery alone. An increased risk of complications was reported because of the suboptimal treatment techniques used. No increase in operative mortality was noted and no impact on survival was reported. Recent non-randomized trials demonstrated more acceptable toxicity with appropriated treatment techniques. Doses of 45-50.4 Gy allowed an high clinical remission rate and downstaging at surgery. A longer interval between radiation therapy and surgery (4-6 weeks) influenced these results and about 75% of patients, who were declared to need an abdominoperineal resection at diagnosis, underwent conservative surgery. Retrospective studies in unresectable disease reported a resectability rate of 39-64% after 45-60Gy of pre-op radiation therapy. Surgical resection demonstrated an impact on survival in most of these patient series. In conclusion, preoperative radiation therapy with conventional fractionation allows downstaging of initial disease with possible impact on local control, sphincter preservation in resectable disease and surgical resection in unresectable disease.

Original languageItalian
Pages (from-to)549-555
Number of pages7
JournalAnnali Italiani di Chirurgia
Volume72
Issue number5
Publication statusPublished - Sep 2001

Fingerprint

Rectal Neoplasms
Radiotherapy
Survival
Retrospective Studies
Mortality
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

La radioterapia preoperatoria nel cancro del retto : Frazionamento convenzionale. / De Paoli, A.; Maranzano, E.; Neri, S.

In: Annali Italiani di Chirurgia, Vol. 72, No. 5, 09.2001, p. 549-555.

Research output: Contribution to journalArticle

@article{1a67f79fa3e74ea68ffad53c69e43d4a,
title = "La radioterapia preoperatoria nel cancro del retto: Frazionamento convenzionale",
abstract = "Experiences on preoperative radiation therapy with conventional fractionation for rectal cancer are reviewed. Results in terms of local control, survival and sphincter preservation are focused in resectable disease: the impact on resectability, local control and survival are analysed in unresectable disease. Randomized trials reported in the 80s, demonstrated a significant impact on local control with a pre-op dose of 34.5-40 Gy vs surgery alone. An increased risk of complications was reported because of the suboptimal treatment techniques used. No increase in operative mortality was noted and no impact on survival was reported. Recent non-randomized trials demonstrated more acceptable toxicity with appropriated treatment techniques. Doses of 45-50.4 Gy allowed an high clinical remission rate and downstaging at surgery. A longer interval between radiation therapy and surgery (4-6 weeks) influenced these results and about 75{\%} of patients, who were declared to need an abdominoperineal resection at diagnosis, underwent conservative surgery. Retrospective studies in unresectable disease reported a resectability rate of 39-64{\%} after 45-60Gy of pre-op radiation therapy. Surgical resection demonstrated an impact on survival in most of these patient series. In conclusion, preoperative radiation therapy with conventional fractionation allows downstaging of initial disease with possible impact on local control, sphincter preservation in resectable disease and surgical resection in unresectable disease.",
keywords = "Adjuvant, Radiotherapy, Rectal neoplasms, Treatment outcome",
author = "{De Paoli}, A. and E. Maranzano and S. Neri",
year = "2001",
month = "9",
language = "Italian",
volume = "72",
pages = "549--555",
journal = "Annali Italiani di Chirurgia",
issn = "0003-469X",
publisher = "Edizioni Luigi Pozzi S.r.l.",
number = "5",

}

TY - JOUR

T1 - La radioterapia preoperatoria nel cancro del retto

T2 - Frazionamento convenzionale

AU - De Paoli, A.

AU - Maranzano, E.

AU - Neri, S.

PY - 2001/9

Y1 - 2001/9

N2 - Experiences on preoperative radiation therapy with conventional fractionation for rectal cancer are reviewed. Results in terms of local control, survival and sphincter preservation are focused in resectable disease: the impact on resectability, local control and survival are analysed in unresectable disease. Randomized trials reported in the 80s, demonstrated a significant impact on local control with a pre-op dose of 34.5-40 Gy vs surgery alone. An increased risk of complications was reported because of the suboptimal treatment techniques used. No increase in operative mortality was noted and no impact on survival was reported. Recent non-randomized trials demonstrated more acceptable toxicity with appropriated treatment techniques. Doses of 45-50.4 Gy allowed an high clinical remission rate and downstaging at surgery. A longer interval between radiation therapy and surgery (4-6 weeks) influenced these results and about 75% of patients, who were declared to need an abdominoperineal resection at diagnosis, underwent conservative surgery. Retrospective studies in unresectable disease reported a resectability rate of 39-64% after 45-60Gy of pre-op radiation therapy. Surgical resection demonstrated an impact on survival in most of these patient series. In conclusion, preoperative radiation therapy with conventional fractionation allows downstaging of initial disease with possible impact on local control, sphincter preservation in resectable disease and surgical resection in unresectable disease.

AB - Experiences on preoperative radiation therapy with conventional fractionation for rectal cancer are reviewed. Results in terms of local control, survival and sphincter preservation are focused in resectable disease: the impact on resectability, local control and survival are analysed in unresectable disease. Randomized trials reported in the 80s, demonstrated a significant impact on local control with a pre-op dose of 34.5-40 Gy vs surgery alone. An increased risk of complications was reported because of the suboptimal treatment techniques used. No increase in operative mortality was noted and no impact on survival was reported. Recent non-randomized trials demonstrated more acceptable toxicity with appropriated treatment techniques. Doses of 45-50.4 Gy allowed an high clinical remission rate and downstaging at surgery. A longer interval between radiation therapy and surgery (4-6 weeks) influenced these results and about 75% of patients, who were declared to need an abdominoperineal resection at diagnosis, underwent conservative surgery. Retrospective studies in unresectable disease reported a resectability rate of 39-64% after 45-60Gy of pre-op radiation therapy. Surgical resection demonstrated an impact on survival in most of these patient series. In conclusion, preoperative radiation therapy with conventional fractionation allows downstaging of initial disease with possible impact on local control, sphincter preservation in resectable disease and surgical resection in unresectable disease.

KW - Adjuvant

KW - Radiotherapy

KW - Rectal neoplasms

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=0035469052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035469052&partnerID=8YFLogxK

M3 - Articolo

C2 - 11975409

AN - SCOPUS:0035469052

VL - 72

SP - 549

EP - 555

JO - Annali Italiani di Chirurgia

JF - Annali Italiani di Chirurgia

SN - 0003-469X

IS - 5

ER -